Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | toll-like receptor 7 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.1862 | 0.1862 |
Leishmania major | serine/threonine protein kinase, putative,protein kinase, putative | 0.0022 | 0.1888 | 1 |
Toxoplasma gondii | histone kinase SNF1, putative | 0.0022 | 0.1888 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.1888 | 0.1888 |
Trypanosoma cruzi | SNF1-related protein kinases, putative | 0.0022 | 0.1888 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trypanosoma brucei | SNF1-related protein kinases, putative | 0.0022 | 0.1888 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Plasmodium falciparum | serine/threonine protein kinase KIN | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Plasmodium vivax | serine/threonine protein kinase KIN, putative | 0.0022 | 0.1888 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0022 | 0.1888 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0116 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trypanosoma cruzi | 5'-AMP-activated protein kinase catalytic subunit alpha, putative | 0.0022 | 0.1888 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Leishmania major | protein kinase, putative,SNF1-related protein kinases, putative | 0.0022 | 0.1888 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Brugia malayi | hypothetical protein | 0.0022 | 0.1862 | 0.1862 |
Giardia lamblia | Kinase, CAMK CAMKL | 0.0022 | 0.1888 | 0.5 |
Echinococcus multilocularis | 5' AMP activated protein kinase catalytic | 0.0116 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Brugia malayi | putative serine/threonine kinase SADA gamma | 0.0022 | 0.1888 | 0.1888 |
Giardia lamblia | Kinase, CAMK CAMKL | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/BRSK protein kinase | 0.0022 | 0.1888 | 0.1888 |
Trypanosoma brucei | 5'-AMP-activated protein kinase catalytic subunit alpha, putative | 0.0022 | 0.1888 | 1 |
Onchocerca volvulus | 0.0012 | 0.1028 | 0.5 | |
Echinococcus multilocularis | serine:threonine kinase SAD 1 | 0.0022 | 0.1888 | 0.1888 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.1862 | 0.1862 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Echinococcus granulosus | 5' AMP activated protein kinase catalytic | 0.0116 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0.1888 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/AMPK protein kinase | 0.0116 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | < 7 microL/min/mg | Intrinsic clearance in human liver microsomes | ChEMBL. | No reference |
EC50 (binding) | > 4000 nM | Agonist activity at TLR7 in 24 hrs compound pre-treated human PBMC assessed as inhibition of HCV replication in human HuH7 cells followed by human PBMC supernatant addition to HCV-infected HuH7 cells measured after 48 hrs by luciferase reporter gene assay | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.